Virbac: sales up by almost 10% in Q1
This increase benefited firstly from a contribution from volumes estimated at around 6.4 growth points, and then, to a lesser extent, from a more modest price effect due in particular to the slowdown in inflation.
For 2024 as a whole, at constant exchange rates and scope of consolidation, Virbac forecasts sales growth estimated, at this stage, at between 4 and 6%, and an adjusted EBIT/sales ratio of around 15%.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction